SlideShare una empresa de Scribd logo
1 de 48
Descargar para leer sin conexión
Obaid Ali & Roohi B. Obaid
Civil Services Officer at Drugs Regulatory Authority of Pakistan
Harmonization Creates Opportunities for Both
Regulatory Professionals and Agencies in
Developing Countries
Roohi B. Obaid & Obaid Ali
Civil Service Officer
at Drug Regulatory Authority of Pakistan
Not the view of DRAP
Current judgment of speaker
No obligation on DRAP
Regulatory experience
It has nothing to do
with any specific
commercial
product
It is just a
knowledge sharing
exercise nothing
more than that
D
I
S
C
L
A
I
M
E
R
Can anyone
assess the Safety
Efficacy &
Quality of the
drug by naked
eye ?
Opening Message
Visible, Sub-visible & invisible Challenges
Harmonization, Globalization & Standardization
Projects & Map of Opportunities
Closing Message
If you want to go fast, go alone
If you want to go far, go together
About Half a billion
population died
4 Lac per year in Europe
Recall the Retard Enemies and Sad Memories
Recall the Retard Enemies and Sad Memories
Small pox Plague Meningitis
Tuberculo
sis
Heart
Attack
Infections Psychiatry Diabetes
Current Issues & Challenges
Hepatitis Ebola
Humans
Their systems
Their pain
S
I
M
I
L
A
R
Humans
Their systems
Their pain
S
I
M
I
L
A
R
Humans
Their systems
Their pain
S
I
M
I
L
A
R
Do disease has a boundary?
Quality Treatment ???
Every human deserves Quality Healthcare
Lets have a look at the back yard
Lets have a look at the back yard
Toxic
solvent
DEG
USA
1937
100s of
deaths
An
antibiotic
elixir
Lets have a look at the back yard
2008
?
Lets have a look at the back yard
Over sulfated chondroitin sulfate (OSCS)
Lets have a look at the back yard
> 100
deaths
PIC
Tragedy
Material
Mix up
New
Tools
Approaches
Standards E
Q
P
S
R
E
G
U
L
A
T
O
R
Y
S
C
I
E
N
C
E
Safety Efficacy Quality
D R U G
Pre Marketing
Review
Inspection
Post Marketing
Evaluation
Challenges
The Regulatory World is highly complex
Science of Regulation
Innovation
Safety
ReasonableBalance
Science of Regulation
Need justifies Outcome
Benefit Risk
Science has one language & speaks with logic
Lets enjoy benefits of science
Doctor
Driver
Technician
Manufacturing
facility
Pharmacist
All require a license to work/practice
Harmonization saves Resources
Harmoniz/sation Works
ICH
Japan
EU
ICH
USA
Observers: WHO & Canada
Balance is required between
Fast Access
Sovereign interest
Western Medicine
Economical Interest
Innovation
Safety
Globalization
Alternative Medicine
Social Interest
Stewardship
International Conference on Harmonization (ICH) Philosophy
Identification and elimination of the
need to duplicate studies to meet
different regulatory requirements
More efficient use of resources in the
R&D process, as a consequence
Quicker access for patients to safe
and effective new medicines
Standardized
Data Elements
Controlled
Vocabularies
Common
Format
Outcomes
Speak same
language
Quality,
accuracy &
consistency
Improve
timeliness
CTD/eCTD
reduces
delays and
costs
Outcomes
Global Regulatory Initiatives
Joint Inspections
Joint investigations
Mutual Recognition
Data sharing
Memorandum of
Understanding
APEC ASEAN GCC PANDRH SADC
A Bridge from ICH to the world beyond
Openness and Transparency
Regional Harmonization Initiatives
International
Compatibility
Way to move forward
Globalization
Regulatory burden
Innovation and Risk
Capacity and
Capability
T
I
M
E
Error
Models of Projects (Example)
Brand Name Analysis
Sound and look alike……
Amaryl
Reminyl
Amaryl
Reminyl
Celebrex
Cerebyx
Celebrex
Cerebyx
Omacor
Amicar
Omacor
Amicar
Intelence (Etravirine) Tablets
Letters in Name
INTELENCE
Scripted may appear
as
Spoken may be interpreted as
I e. L any vowel
n v, r, s, m
t f, r, x d
e i, l any vowel
l b, e, h
c a, r S
Look a like and sound alike letters
Relative Scale of Concerns
N
G
B
S E Q
S E Q
QES
Pre-Market Compliance Post-Market
G
B
N
Safety
Efficacy
Quality
Equal voice
Consistency & Uniformity in decision
Question based Review & Critical Thinking
Organizational Approach
Learn, De-learn & Re-learn
Thanks

Más contenido relacionado

La actualidad más candente

Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market
Outsourcing in Drug Development: The Contract Research (Clinical Trial) MarketOutsourcing in Drug Development: The Contract Research (Clinical Trial) Market
Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market
MarketResearch.com
 

La actualidad más candente (20)

INSHAALLAH
INSHAALLAHINSHAALLAH
INSHAALLAH
 
AzCI presents: FDA Drug Development 101
AzCI presents: FDA Drug Development 101AzCI presents: FDA Drug Development 101
AzCI presents: FDA Drug Development 101
 
1 of 5 Welcome Note by Roohi B. Obaid
1 of 5 Welcome Note by Roohi B. Obaid1 of 5 Welcome Note by Roohi B. Obaid
1 of 5 Welcome Note by Roohi B. Obaid
 
Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market
Outsourcing in Drug Development: The Contract Research (Clinical Trial) MarketOutsourcing in Drug Development: The Contract Research (Clinical Trial) Market
Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market
 
Role of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug DevelopmentRole of CRO’s in Medical Innovation and Drug Development
Role of CRO’s in Medical Innovation and Drug Development
 
4 of 5 Quality; A Lifestyle for Success by Iftikhar A. Jafri
4 of 5   Quality; A Lifestyle for Success by Iftikhar A. Jafri4 of 5   Quality; A Lifestyle for Success by Iftikhar A. Jafri
4 of 5 Quality; A Lifestyle for Success by Iftikhar A. Jafri
 
Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar SlidesPan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
Pan-Canadian Pharmaceutical Alliance – a Primer June 22, 2016 Webinar Slides
 
Clincal Research Training - Dr Tim Grant, StatisticaMedica - Dec 7th 2016
Clincal Research Training - Dr Tim Grant, StatisticaMedica - Dec 7th 2016Clincal Research Training - Dr Tim Grant, StatisticaMedica - Dec 7th 2016
Clincal Research Training - Dr Tim Grant, StatisticaMedica - Dec 7th 2016
 
"Pharmacovigilance in Crisis: Drug Safety at a Crossroads, 2018".
"Pharmacovigilance in Crisis: Drug Safety at a Crossroads, 2018"."Pharmacovigilance in Crisis: Drug Safety at a Crossroads, 2018".
"Pharmacovigilance in Crisis: Drug Safety at a Crossroads, 2018".
 
Obaid & Roohi Centre for Quality Sciences - ORCQS
Obaid & Roohi Centre for Quality Sciences - ORCQSObaid & Roohi Centre for Quality Sciences - ORCQS
Obaid & Roohi Centre for Quality Sciences - ORCQS
 
A Talk on Pharmaceutical Quality
A Talk on Pharmaceutical QualityA Talk on Pharmaceutical Quality
A Talk on Pharmaceutical Quality
 
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
Pharma-CRO Relationships Managing Risk A Lawyer\'s ViewPharma-CRO Relationships Managing Risk A Lawyer\'s View
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
 
WebeX Presentation - Quality Consortium
WebeX Presentation - Quality ConsortiumWebeX Presentation - Quality Consortium
WebeX Presentation - Quality Consortium
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
Regulatory Affairs Certification Dumps
Regulatory Affairs Certification DumpsRegulatory Affairs Certification Dumps
Regulatory Affairs Certification Dumps
 
The Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical DevelopmentThe Statisticians Role in Pharmaceutical Development
The Statisticians Role in Pharmaceutical Development
 
Create a Difference
Create a DifferenceCreate a Difference
Create a Difference
 
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
 
Creating and Protecting a Culture of Quality to Enhance Certainty
Creating and Protecting a Culture of Quality to Enhance CertaintyCreating and Protecting a Culture of Quality to Enhance Certainty
Creating and Protecting a Culture of Quality to Enhance Certainty
 

Destacado

Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu... Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
Obaid Ali / Roohi B. Obaid
 
2. Design, Trust & Control of Sterile Manufacturing (Particles)
2. Design, Trust & Control of Sterile Manufacturing (Particles)2. Design, Trust & Control of Sterile Manufacturing (Particles)
2. Design, Trust & Control of Sterile Manufacturing (Particles)
Obaid Ali / Roohi B. Obaid
 
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
Obaid Ali / Roohi B. Obaid
 
4. Design, Trust & Control of Sterile Manufacturing (Observations)
4. Design, Trust & Control of Sterile Manufacturing (Observations)4. Design, Trust & Control of Sterile Manufacturing (Observations)
4. Design, Trust & Control of Sterile Manufacturing (Observations)
Obaid Ali / Roohi B. Obaid
 

Destacado (20)

Review of Control Strategy of GMP March 2014
Review of Control Strategy of GMP March 2014Review of Control Strategy of GMP March 2014
Review of Control Strategy of GMP March 2014
 
Pharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & ComplexityPharmaceutical Regulaions; Emergence & Complexity
Pharmaceutical Regulaions; Emergence & Complexity
 
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu... Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
Group-A, Day 1: CLINICAL TRIAL, Rising Regulations & Complexities, Pharmaceu...
 
2. Design, Trust & Control of Sterile Manufacturing (Particles)
2. Design, Trust & Control of Sterile Manufacturing (Particles)2. Design, Trust & Control of Sterile Manufacturing (Particles)
2. Design, Trust & Control of Sterile Manufacturing (Particles)
 
1 OARO-Fundamentals-04 Feb 2017
1  OARO-Fundamentals-04 Feb 20171  OARO-Fundamentals-04 Feb 2017
1 OARO-Fundamentals-04 Feb 2017
 
From Terminal Sterlization to Aseptic Manufacturing of Perentral Products: Gu...
From Terminal Sterlization to Aseptic Manufacturing of Perentral Products: Gu...From Terminal Sterlization to Aseptic Manufacturing of Perentral Products: Gu...
From Terminal Sterlization to Aseptic Manufacturing of Perentral Products: Gu...
 
4 OARO-Case Studies-04 Feb 2017
4  OARO-Case Studies-04 Feb 20174  OARO-Case Studies-04 Feb 2017
4 OARO-Case Studies-04 Feb 2017
 
Pharmaceutical Engineering Forum 28 Jan 2017 (135 Slides)
Pharmaceutical Engineering Forum 28 Jan 2017 (135 Slides)Pharmaceutical Engineering Forum 28 Jan 2017 (135 Slides)
Pharmaceutical Engineering Forum 28 Jan 2017 (135 Slides)
 
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
1. Design, Trust & Control of Sterile Manufacturing (Opening Note)
 
Claim & Reasonable Probability
Claim & Reasonable ProbabilityClaim & Reasonable Probability
Claim & Reasonable Probability
 
Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)Claim & Reasonable Probability (Part 2)
Claim & Reasonable Probability (Part 2)
 
April 08th 2015, Forum on Generic Drugs & Promise of Regulatory Science 3/3
April 08th 2015, Forum on Generic Drugs & Promise of Regulatory Science 3/3April 08th 2015, Forum on Generic Drugs & Promise of Regulatory Science 3/3
April 08th 2015, Forum on Generic Drugs & Promise of Regulatory Science 3/3
 
19 & 25 April (Day 2) PBRS 2015
19 & 25 April (Day 2) PBRS 2015 19 & 25 April (Day 2) PBRS 2015
19 & 25 April (Day 2) PBRS 2015
 
4. Design, Trust & Control of Sterile Manufacturing (Observations)
4. Design, Trust & Control of Sterile Manufacturing (Observations)4. Design, Trust & Control of Sterile Manufacturing (Observations)
4. Design, Trust & Control of Sterile Manufacturing (Observations)
 
07 June (Day 6) PBRS 2015 PMS & DS
07 June (Day 6) PBRS 2015 PMS & DS07 June (Day 6) PBRS 2015 PMS & DS
07 June (Day 6) PBRS 2015 PMS & DS
 
Manufacturing of Sterile Products Session 3 of 3-OA-13 May 2015
Manufacturing of Sterile Products Session 3 of 3-OA-13 May 2015Manufacturing of Sterile Products Session 3 of 3-OA-13 May 2015
Manufacturing of Sterile Products Session 3 of 3-OA-13 May 2015
 
Manufacturing of Sterile Products Session 1 of 3-OA-13 May 2015
Manufacturing of Sterile Products Session 1 of 3-OA-13 May 2015Manufacturing of Sterile Products Session 1 of 3-OA-13 May 2015
Manufacturing of Sterile Products Session 1 of 3-OA-13 May 2015
 
Draft Guidance on Physical Attributes of Tabs & Caps
Draft Guidance on Physical Attributes of Tabs & CapsDraft Guidance on Physical Attributes of Tabs & Caps
Draft Guidance on Physical Attributes of Tabs & Caps
 
Broadband Retail Price Regulation Pakistan Case Study 30 07 2011
Broadband Retail Price Regulation Pakistan Case Study 30 07 2011Broadband Retail Price Regulation Pakistan Case Study 30 07 2011
Broadband Retail Price Regulation Pakistan Case Study 30 07 2011
 
8 April 2015 Forum on Generic Drugs & Promise of Regulatory Science
8 April 2015 Forum on Generic Drugs & Promise of Regulatory Science8 April 2015 Forum on Generic Drugs & Promise of Regulatory Science
8 April 2015 Forum on Generic Drugs & Promise of Regulatory Science
 

Similar a Harmonization and Opportunites (Nov 2015)

Rochak presentation....current challenges of pharmacovegilence
Rochak presentation....current challenges of pharmacovegilenceRochak presentation....current challenges of pharmacovegilence
Rochak presentation....current challenges of pharmacovegilence
rochaksoni
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
Pinky Fadullon
 
10x-Program-2015
10x-Program-201510x-Program-2015
10x-Program-2015
davesheppa
 
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
Pristyn Research Solutions
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
CincyTechUSA
 
Women's health network dr
Women's health network drWomen's health network dr
Women's health network dr
Dianne Reynolds
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
TTC, llc
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
TTC, llc
 

Similar a Harmonization and Opportunites (Nov 2015) (20)

Pharma Asia (24th August 2017)
Pharma Asia (24th August 2017)Pharma Asia (24th August 2017)
Pharma Asia (24th August 2017)
 
1 OA ICH Background
1 OA ICH Background1 OA ICH Background
1 OA ICH Background
 
Rochak presentation....current challenges of pharmacovegilence
Rochak presentation....current challenges of pharmacovegilenceRochak presentation....current challenges of pharmacovegilence
Rochak presentation....current challenges of pharmacovegilence
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
 
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
DIA Global Forum: Are Clinical Trials Ready to Embrace the IoE?
 
WHO Contribution to impementing MeTA
WHO Contribution to impementing MeTAWHO Contribution to impementing MeTA
WHO Contribution to impementing MeTA
 
10x-Program-2015
10x-Program-201510x-Program-2015
10x-Program-2015
 
Dashboard Review; An Outline 2017
Dashboard Review; An Outline 2017Dashboard Review; An Outline 2017
Dashboard Review; An Outline 2017
 
What's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science CoachWhat's In An Idea-Chanda-UofT Life Science Coach
What's In An Idea-Chanda-UofT Life Science Coach
 
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...PHARMACOVIGILANCE  COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
PHARMACOVIGILANCE COMMON JOB INTERVIEW QUESTIONS WITH ANSWERS-Updated IN 202...
 
AzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and ApprovalAzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and Approval
 
The Rise and Rise of HCPs' Social Networks - Focus on GCC Region
The Rise and Rise of HCPs' Social Networks - Focus on GCC RegionThe Rise and Rise of HCPs' Social Networks - Focus on GCC Region
The Rise and Rise of HCPs' Social Networks - Focus on GCC Region
 
World Water Week 2019: Reducing Emissions from Antibiotics Production (REAP)
World Water Week 2019: Reducing Emissions from Antibiotics Production (REAP)World Water Week 2019: Reducing Emissions from Antibiotics Production (REAP)
World Water Week 2019: Reducing Emissions from Antibiotics Production (REAP)
 
Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013Challenges for drug development jsr slides aug 2013
Challenges for drug development jsr slides aug 2013
 
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory CommitteeODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
ODAC: Preparing For Successful Interactions w/ Oncology Drugs Advisory Committee
 
Vedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CROVedic Lifesciences - Nutraceutical CRO
Vedic Lifesciences - Nutraceutical CRO
 
Drug Regulatory Affairs pdf
Drug Regulatory Affairs pdfDrug Regulatory Affairs pdf
Drug Regulatory Affairs pdf
 
Women's health network dr
Women's health network drWomen's health network dr
Women's health network dr
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani ZakiFuture Challenges of Clinical Development; a View from the CRO - Hani Zaki
Future Challenges of Clinical Development; a View from the CRO - Hani Zaki
 

Más de Obaid Ali / Roohi B. Obaid

Más de Obaid Ali / Roohi B. Obaid (20)

A Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological ProductsA Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological Products
 
Centre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdfCentre for Quality Sciences-Information File-2024.pdf
Centre for Quality Sciences-Information File-2024.pdf
 
A Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdfA Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdf
 
230930.pdf
230930.pdf230930.pdf
230930.pdf
 
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdfDemonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
 
Centre for Quality Sciences-2023
Centre for Quality Sciences-2023Centre for Quality Sciences-2023
Centre for Quality Sciences-2023
 
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdfTrack, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
 
Confidence on Generics.pdf
Confidence on Generics.pdfConfidence on Generics.pdf
Confidence on Generics.pdf
 
Neurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdfNeurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdf
 
Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4
 
PICS-ICH
PICS-ICHPICS-ICH
PICS-ICH
 
Quality Affairs of Pharmaceuticals
Quality Affairs of PharmaceuticalsQuality Affairs of Pharmaceuticals
Quality Affairs of Pharmaceuticals
 
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
 
CQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdfCQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdf
 
GMP Session for Professional Development.pdf
GMP Session for Professional Development.pdfGMP Session for Professional Development.pdf
GMP Session for Professional Development.pdf
 
Q & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdfQ & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdf
 
Judging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the LineJudging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the Line
 
Maturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver PromiseMaturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver Promise
 
PQRS 2022 - Education
PQRS  2022 - EducationPQRS  2022 - Education
PQRS 2022 - Education
 
4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf
 

Último

Beyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable developmentBeyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable development
Nimot Muili
 
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTECAbortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Riyadh +966572737505 get cytotec
 
Agile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptxAgile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptx
alinstan901
 

Último (15)

Beyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable developmentBeyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable development
 
Reviewing and summarization of university ranking system to.pptx
Reviewing and summarization of university ranking system  to.pptxReviewing and summarization of university ranking system  to.pptx
Reviewing and summarization of university ranking system to.pptx
 
internal analysis on strategic management
internal analysis on strategic managementinternal analysis on strategic management
internal analysis on strategic management
 
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTECAbortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
 
Independent Escorts Vikaspuri / 9899900591 High Profile Escort Service in Delhi
Independent Escorts Vikaspuri  / 9899900591 High Profile Escort Service in DelhiIndependent Escorts Vikaspuri  / 9899900591 High Profile Escort Service in Delhi
Independent Escorts Vikaspuri / 9899900591 High Profile Escort Service in Delhi
 
How Software Developers Destroy Business Value.pptx
How Software Developers Destroy Business Value.pptxHow Software Developers Destroy Business Value.pptx
How Software Developers Destroy Business Value.pptx
 
Agile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptxAgile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptx
 
Safety T fire missions army field Artillery
Safety T fire missions army field ArtillerySafety T fire missions army field Artillery
Safety T fire missions army field Artillery
 
Dealing with Poor Performance - get the full picture from 3C Performance Mana...
Dealing with Poor Performance - get the full picture from 3C Performance Mana...Dealing with Poor Performance - get the full picture from 3C Performance Mana...
Dealing with Poor Performance - get the full picture from 3C Performance Mana...
 
Marketing Management 16th edition by Philip Kotler test bank.docx
Marketing Management 16th edition by Philip Kotler test bank.docxMarketing Management 16th edition by Philip Kotler test bank.docx
Marketing Management 16th edition by Philip Kotler test bank.docx
 
Leaders enhance communication by actively listening, providing constructive f...
Leaders enhance communication by actively listening, providing constructive f...Leaders enhance communication by actively listening, providing constructive f...
Leaders enhance communication by actively listening, providing constructive f...
 
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
 
Strategic Management, Vision Mission, Internal Analsysis
Strategic Management, Vision Mission, Internal AnalsysisStrategic Management, Vision Mission, Internal Analsysis
Strategic Management, Vision Mission, Internal Analsysis
 
International Ocean Transportation p.pdf
International Ocean Transportation p.pdfInternational Ocean Transportation p.pdf
International Ocean Transportation p.pdf
 
Intro_University_Ranking_Introduction.pptx
Intro_University_Ranking_Introduction.pptxIntro_University_Ranking_Introduction.pptx
Intro_University_Ranking_Introduction.pptx
 

Harmonization and Opportunites (Nov 2015)